News | March 13, 2023
Zydus receives final approval from the USFDA for Olanzapine
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Subscribe To Our Newsletter & Stay Updated
